On July 21, Twist Bioscience Corp fell 5.04% in regular trading, trading at $89.02 USD/share, with Turnover of $32.14 million.
Within the Biotechnology sector where Twist Bioscience belongs, the overall sector showed broad weakness. Among individual stocks, AbbVie down 0.6%, Vertex Pharmaceuticals down 0.07%, Amgen down 0.34%, Gilead Sciences down 0.56%, Alnylam Pharmaceuticals up 1.84%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)